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Copper and Diclofenac (DCL) separately, are used to alleviate 
inflammation associated with RA. It has been postulated that their 
combination woud have a synergistic effect i.e., their combination 
would be more effective than when administered independently. 
Cu(II)-DCL system is studied potentiometrically in order to evaluate 
this hypothesis. Because of solubility limitations the system was 
studied in 50% M,~OH/H20 and in water with f)-cyclodextrin (f)-CD) as 
a carrier molecule. Protonation constants of 4.82 and 4.29 were 
obtained m a 50% MeOH/H20 mixture and f)-CD solution 
respectively. Based on pKa values, and the pH at which precipitation 
occurred, the solubility products of 5 xlO-8M2 and 6.9 xl0-8M2 were 
calculated for the protonated DCL in the two media respectively. The 
improvement in solubility products is due to the difference in 
protonation constants for the two media used. 
Because of solubJity problems, it was not possible to investigate the 
copper complex d the ligand using the f)-CD environment. The only 
log stability constants obtained were 3.48 and -3.02 for the 1 1 0 and 
1 1 -1 species respectively in 50% MeOH/H20. Computer simulation 
of intestinal abso;-ption indicates that the CuDCL complex would exist 
at pH > 5 which improve the bioavailability of both the copper and 
DCL. However blood plasma simulation studies indicated that the 
ligand is devoid of any Cu(II) mobilising ability. DCL is then unable to 
























Disease modifying antirheumatic drug 
Evaluation of constituent concentrations in large 
equilibrium systems 
Electromagnetic force 
Equilibrium simulation for titration analysis 
Glass Electrode Potentiometry 
Gly Glycine 
MeOH\H20 Methanol\ water 
NMR Nuclear magnetic resonance 










ESTA task for optimising titration parameters with respect 
to e1T(ftitration points 
Prostaglandin 
Plasma mobilising index 
ESTA task for calculating the deprotonation function 
Rheumatoid Arthritis 
Supe::oxide dismutase 
ESTA task for calculating the species distribution of the 
component chemical species 
Tu berculosis 











List of figure s and tables 
Figures 
1a The structure of sodium diclofenac 
1 b Cyclodextrin inclusion of diclofenac 
2. Glycinate ion 
3. The glycinato chelate ring 
4. ZBAR curves for glycine titrations at 25° C 
5. ZBAR curves for Copper Glycine titrations at 25' C 
6. ZBAR curves for Diclofenac titrations at 25' C 
7. ZBAR curves for ~CD-Diclofenac titrations at 25' C 
8. Cyclodextrin inclusion 
9. ZBAR curves for DCL in 50%MeOH\H20 at 25'C 
10. ZBAR curves for Cu-MetDiclofenac at 25'C 
11. QBAR curves for Cu-MetDiclofenac at 25'C 
12. UV jVisible CU-Glycine Spectra 
13. Spectrum of CuGly species 
14. UV jVisible Diclofenac Spectra 
15. UV jVisible Cu-Diclofenac Spectra 
16. NMR Spectra for DCL at pH 8.3 in 50%MeOH/H20 
17. NMR data analysis for DCL protons in ~CD 
18. DCL speciation in MeOH as a function of pH 
19. DCL speci3.tion in ~CD as a function of pH 
20. Speciation distribution of CuDCL as a function of pH 
Tables 
1. Non steroidal antiinflammatory drugs 
2. Disease modifying antirheumatic drugs 
3. The stability constants for the Cu(II) glycinate system 
4. The stability constants for the Cu(II)-Diclofenac system 
5. The absorption maxima of the Cu (II) ammine 



















































Introduction ______ _ Page 1 
1. Introduction 
Inflammation i~, an important response to tissue injury due to any 
cause. The imp::>rtance of this multifaceted process is best appreciated 
as the beginning of the tissue repair process which is required to re-
establish normal function. 1 Persistent inflammation in the absence of 
tissue repair a:ld the resultant lack of normal function is recognised 
as chronic inflammation. An "anti-inflammatory" agent that inhibits 
some facet of the inflammatory process and, as a result, the repair 
process would not be expected to re-establish normal function. 
Alternatively, an anti-inflammatory agent which facilitates the repair 
process would be expected to re-establish normal function. 1 Similarly, 
inflammation can affect the lining of the joints so that they too become 
hot, swollen and painful. The joint then becomes difficult to move and 
does not ben::! as far as it should. 2 Eventually the joint may be 
considerably damaged and internal scarring may stop it moving freely. 
The most common cause of inflammation of this type occurring in 
several joints :n one person is Rheumatoid Arthritis (RAJ. 
1.1 Rheumatoid Arthritis(RA) 
Rheumatoid A.rthritis (RAJ, is a debilitating disease, afflicting some 5% 
of the Western World's population and there is no cure yet. 1 RA is the 
most severe of the arthritis disorders. The word "Arthritis" simple 
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In the normal synovial joint, articular cartilage covers the bone ends 
and both are enclosed by a synovial membrane. Articular cartilage is 
the dense tissne containing collagen fibres and cells (chondrocytes) 
embedded in a matrix of proteoglycan. The normal synovial lining of 
the joint exists as thin fibrous tissue which is made up of lining cells 
(synoviocytes) overlying fatty and fibrous material. 
The synovialiining synthesizes the polymer hyaluronic acid and 
secretes it into the synovial fluid, where it is largely responsible for the 
viscosity of the fluid. The synovial lining also acts as a barrier to the 
free movement of proteins from plasma into the synovial fluid. 4 
RA is a commen condition. It affects something like one in every fifty 
of the adult population, but fortunately most of these people are only 
mildlyaffected.3 Indeed some have such a mild attack that they do 
not feel ill eno".lgh to consult their doctors. 
They noticed temporary pain and swelling in their joints, perhaps in 
their fingers, but after a few weeks the symptoms disappear and there 
is no further trouble. 3 For others, however, the condition does not 
settle down and it is they who seek medical help. A minority of this 
group who are more seriously affected go on to develop severe 
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RA is much more common in women than in men. For every man 
affected there are two or three women with this disease. The reason 
for this difference is not clear. 3 RA usually begins between the age of 
thirty and sixty but there is evidence that it can start at any age. It 
has been recorded that the disease involved an infant of only nine 
months and at the other extreme of life span, the condition can 
develop for the first time in elderly people, even in those over the age 
of ninety.3 
1.1.1 What is the cause? 
It has been said " ... everything is known about RA except its cause, 
natural history and treatment. It is one of the perversities of the 
human conditlon that the rarer the disease, the more clearly it seems 
to be understc,od". 5 
The body inadvertently alters its defence mechanisms so as to attack 
its own linings i.e. the synovium. The explanation comes from the 
observation that the joint linings show changes which are similar to 
those seen in any part of the body in which an "antibody" reaction is 
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1.1.2 What happens in RA 
The onset of rheumatoid arthritis is usually slow. 6 The first noticeable 
changes are swelling and inflammation of the lining of the joint-
synovium. This becomes abnormally thick and swollen due to the 
persistent inflammation, and eventually it grows and spreads over the 
surface of the joint.6 Its permeability increases, so that more plasma 
contents enter the joint. Iron deposition is seen within the synovial 
cells; much of this iron occurs within ferritin and haemosiderin. 6 
In many patients with rheumatoid arthritis, the disease leads to the 
destruction of the articular cartilage, bone erosion, and impairment of 
joint function 6 Here it can, if it goes on long enough, damage the 
underlying cartilage, which is the natural load-bearing surface of the 
joint. Eventually it "eats" its way through, causing irreversible damage 
to the normal smooth slippery joint surface.3 
The ligaments which provide stability to the joint are also weakened so 
that not only .,s the efficiency of the joint greatly diminished but it also 
becomes unstable. 3 Damage and pain can ensue because the joint is 
moved in directions or degrees for which it was not originally 
designed. Inflammation can also occur in tissues under the skin 












This is the result of leaning forwards on the forearms when resting at 
a table. Small lumps called R nodules develop which can grow and 
become tender 3 This means that there may be changes elsewhere. 5 
The first symptoms of arthritis are often just generalised aches and 
pains. Stiffness of the hands and the other joint is a common feature. 
This is noticea ble first thing in the morning and it may take several 
hours to disappear. At this stage sufferers complain more of this than 
of pain. 6 
Later with the further development of arthritis, the joints became 
swollen and painful. When pressed upon they feel tender and an 
attempt to use them generates pain. Because of this, the sufferer tries 
to avoid using the affected joints with the danger that movement 
becomes more and more restricted. 
There are certain joints, which are especially prone to be affected by 
RA. These are the finger joints, the wrist, knees and those at the bases 
of the toes. 6 The disease can occur in joints such as the ankles, 
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1.2 Treatment of RA 
A massive research program has been launched in the last few years 
in an attempt to determine the cause of RA.3 Indeed the pace of 
medical research is such that we reasonably hope to find the cure for 
RA one day. 
But even if we cannot talk of a cure yet, there are several methods of 
treating this disease which are important as means of providing relief 
from pain, preventing unnecessary deformities and enabling the 
sufferer to be as independent as possible. 3 These treatments are 
divided into rest, occupational therapy aids, splints and plasters, 
physiotherapy, drugs and surgery.4 Two of these are discussed below. 
(i) The importance of rest: 
There is no doubt that periods of rest are of the greatest value to 
patients with RA. When the disease is really severe then complete bed 
rest is essential. People are often admitted to hospital purely for this 
reason alone. 3 
(ii) Medical control of RA 
Since RA cannot be cured, it can only be alleviated also by drug 
therapy. Drugs are foreign compounds to the body and therefore they 
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Chapter One Introduction 
There are drugs that are aimed at inhibiting the pain and suppress 
inflammation and are widely used for arthritis. These are non-
steroidal anti -inflammatory drugs (NSAIDs), disease-modifying 
antirhemautic drugs (DMARDs) and glucocorticoids. 
(a) NSAIDs. 
The actual mechanisms of drug action are complicated, but some 
explanation can make understanding them easier.6 NSAIDs are often 
essential agents in the management of arthritis and have a major role 
in the management of pain, but they also may be commonly employed 
for conditions that are less serious. NSAIDs work quickly when they 
are given and the effects wear off quickly when they are withdrawn. 7 
Aspirin 3 (acetylsalicylic acid) is a familiar drug for relieving pain and 
as such it is tne most useful drug for treating RA. If taken in the full 
dosage it wi} actually suppress the inflammation. Also, many 
clinicians believe that higher doses of these NSAIDs are more effective 
than lower doses for the treatment of RA but are associated with 
higher rates of adverse events. 17 There are also other (NSAIDs)8 
ibuprofen ane acetaminophen. These are widely used for their ability 
to decrease inflammation and pain.8 
Examples of "1SAIDs are shown in Table 1 below and also the next 
class of drugs employed in the medical control of RA is DMARD shown 
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(b) DMARDs 
These drugs are aimed not only in treating the symptoms but also at 
suppressing the disease at the source by diverting the course of the 
pathologic reactions. 9 The drug has to be administered over a long 
period of time because remission may occur at termination of therapy. 
Table 2: Disease modifying antirheumatic drugs8 
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There are also synthetic corticosteroids that form part of RA drug 
regimen. 9 Thel,e are steroid and cortisone preparations. 3 When 
naturally occurring in the body they take part in many physiological 
chemical reactions. Example of such drugs, which is of relevance to 
the management of RA, is glucocorticoids.9 
(c) Glucocorticoids 
These have been synthesised and made into preparations for use in 
the treatment of tissue inflammation. They act to reduce heat, 
swelling and tenderness at the inflamed joint. Even though their mode 
of action is unclear, they have proved to be the best at combating 
inflammation. There is however, one overriding disadvantage in the 
use of corticosteroids for RA treatment. They are neither antiviral nor 
antibacteriaL 10 They may seem to be very effective at the alleviation of 
the RA symptoms whilst they are actually obscuring the damage done 
by microbes in the body. 
1.3 Prostaglandins in RA treatment. 
In 1971 J. R. Vane ll proposed the hypothesis that the anti-
inflammatory effects of aspirin were due to its ability to inhibit 
prostaglandin synthesis. The discovery by Vane that both the 
therapeutic and the toxic effects of NSAIDs are produced by their 
action in preventing the synthesis of prostaglandins (PGs) by 
inhibition of COX enzymes was undoubtedly one of the landmark 












These mechanisms do not explain, however, why different drugs 
administered a: equi-active therapeutic doses exhibit side effects of 
different seventy, and why there is limited correlation between 
inhibition of PC biosynthesis and anti-inflammatory activity. However, 
inhibition of cyc100xygenase (COX) activity is only one action of 
NSAIDs.ll 
1.4 The role of Cyc100xygenase (COX) in inflammation. 
Recently, two different COX isoforms have been characterised: COX-1 
and COX_2.12 ~nhibition of COX-1 and/ COX-2 leads to very different 
pharmacological effects. The COX-l inhibition is predominantly 
responsible for anti-thrombotic effects and is expressed in all tissues 
while anti-inflammatory effects are mediated mainly by COX-2 and is 
predominant i"l the kidney, brain and ovaries. 12 
Both these COX isoenzymes are present in human rheumatoid 
synovial fluid, but only COX2 is regulated by interleukin-1. 13 Human 
rheumatoid joints contain many inflammatory cytokines which also 
up-regulate COX2 expression. 13 When a cell membrane is injured, 
arachidonic acid is released into the cell where it is oxidised (broken 
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The by-products of this reaction are called endoperoxides and are 
converted into PGs. In inflamed tissue, PGs produced by COX2 cause 
a variety of effects including fever, swelling, redness, accumulation of 
white blood cells, and stimulation of bone resorption. 14 Its mode of 
action is suggested to be the inhibition of COX-2, which is the cytikine 
inflammatory inducible enzyme, while its action on the physiologically 
responsive COX-l is minimal. 12 
NSAIDs decrease injury by acting as anti-oxidants as well as blocking 
PG formation by inhibiting COX2 enzymes, which decrease fever, 
swelling, and pain. IS These side effects are why other medications are 
prescribed in addition and is probably the inhibition of this enzyme 
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Chapter Two Motivational Study 
2. Motivational Study 
2.1 Background on the Study 
2.1.1 ,Piclofenac ig RA. 
Page 13 
Diclofenac (DeL) is a potential NSAID, therapeutically used In 
inflammatory diseases of rheumatic and non-rheumatic origin.l It 
relieves pain and reduces swelling in the treatment of rheumatoid 
arthritic, (including arthritis In children), osteoarthritic and 
ankylosing spondylitic (inflammation of the joints between the spine 
and pelvis) patients. 2 Its action on the response of COX-1 is minimaL 
In vitro inhib:tion of COX by DCL does not translate to in vivo 
inhibition. Diclofenac is also found to decrease prostaglandins directly 
in synovial fluid in humans and in urine and renal medula in rats and 
pigS.3 
Dic10fenac has been found to interact in vivo with arachidonic acid 
cascade at the level of COX.3 The anti-inflammatory activity of 
dic10fenac and most of its other pharmacological effects are thought to 
be related to the inhibition of the conversion of arachidonic acid to 
prostaglandin s, which are the mediators of the inflammatory process. 4 
Like other NSAIDs, dic10fenac is highly (>95%) protein bound.s DCL is 
also a potential reversible inhibitor of the secondary phase of induced 











Chapter Two Motivational Study Page 14 
Diclofenac (Figure 1 below), as the sodium salt, is a benzene acetic 
acid derivative. It is designated chemically as sodium 2-[(2,6-
dichlorophenyl) amino] benzene acetic acid. 6 The structure of 
diclofenac consests of a phenyl acetic acid group, a secondary amino 
group, and a phenyl ring, both ortho positions are occupied by 
chlorine atoms causing a torsion angle of 70 and 69 respectively 
between the two aromatic rings. It is freely soluble in methanol, 
soluble in ethanol and sparingly soluble in water.6 
Diclofenac, like other drugs of its class, is not free of side effects. The 
side effects of these drugs can cause discomfort and rarely, more 
serious side effects, such as gastrointestinal bleeding, liver toxicity, 
which may result in hospitalisation and even fatal outcomes. s 
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2.1.2 Role of Cyclodextrins in pharmaceutical industry. 
In the last few years, pharmaceutical modification of drug molecules 
by inclusion has been extensively developed to improve their 
solubility, chemical stability, absorption and bioavailability.7 
Microencapsulation of drug molecules in cyclodextrins (CDs) has been 
extensively used in the pharmaceutical industry to produce more 
stable drug preparations with improved bioavailability.8 Host-guest 
interactions in CD complexes include hydrogen bonding, hydrophobic 
binding and polar interactions, some or all of which may contribute to 
complex stabilization, depending on the chemical nature of the guest 
and that of the CD. CDs are cyclo amyloses containing a-CD and ~-CD 
having the polar hydrophilic outside and a relatively non-polar 
lipophilic inside which lead naturally to two important results: - (i) 
using its lipophilic interior, a CD typically takes as a guest, a non-
polar organic molecule or the non-polar end of an organic molecule. 
(ii) Its hydrophilic exterior, on the other hand, confers water solubility 
to the resulting complex (as shown by Figure Ib). 
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2.1.3 B-CD 
The inclusion complexation of drug molecules by I3-CD has been 
extensively studied. 9 It has been found that I3-CD greatly improves the 
pH dependent solubility of NSAIDs. These have been used in various 
ways such as 10 accelerate or retard organic reactions or as simple 
models of enzymatic reactions. I3-CD has been applied to numerous 
reactions related to hydrolysis and decarboxylation. 9 In the present 
work, the guest-host complexation has been investigated by using 
potentiometry. 
2.1.4 .QQ:m2er Activity in RA., 
The relationship of copper to RA is complex,lO it has been linked to RA 
for centuries. Folk-lore treatment of arthritis invariably involves 
copper, either in a copper-rich diet such as shellfish, nuts and cider 
vinegar, or the ubiquitous copper bangle. 24 Walker et al,25, 11 have 
measured the dermal absorption of copper from bracelets and found it 
to be significant. This has been shown by counting the activity that 
the copper(II) complex perfuses the skin and over a period of 6-7 hr 
reaches the iE.otonic saline solution underneath. After this inaugural 
delay period a steady rate of penetration was maintained and after 24 
hr about 1 mg of the complex perfused the skin. Histological 
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However, the possible acceptance of this form of therapy was impeded 
by the development of aspirin-like non-steroid anti-inflammatory 
drugs (NSAICs), DMARDs and anti-inflammatory steroids 
(glucocorticoids). In 1960 Bonta12 showed that copper compounds 
possessed anti-inflammatory effects in animals and Sorenson2 
confirmed these findings.14 It was speculated that anti-arthritic agents 
might promote tissue redistribution of elevated serum copper in RA 
patients, which was a physiological response to the inflammation. 15 
Studies examining the effect of copper on inflammation have recently 
been the subject of considerable attention. 16 The objective, then, in 
designing copper based anti-inflammatory drugs, has been to increase 
the concentration of the low molecular mass, membrane penetrable 
plasma fraction of copper. 23 
This may be achieved in three ways: 
1. Copper may be released from ceruloplasmin or some other inert 
copper store. This approach would be the most difficult as it would 
involve chemical degradation of the protein or reductive chelation 
of the metaL 
2. The copper reversibly bound to serum albumin may be removed 
using a powerful low molecular weight copper complexing ligand. 
3. Copper could be administered orally or topically as a neutral, 
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Ultimately, the only way of testing drug efficiency is \vith animal 
screens. 17 The increase in serum copper that occurs after copper 
complex administration IS also dependent on the route of 
administration and the species administered. 16 Furthermore since an 
elevated serum copper level is a feature of RA, prophylactic effects 
have been asse ssed of a variety of drugs of the copper levels. These 
effects have been correlated with the anti-arthritic activity of the 
drugs. 18 Presently, a large amount of data indicates that endogenous 
copper plays an important role in many biochemical processes,18 some 
of which are closely connected with inflammation. 19 
Sorenson 20 and Jackson 21 et al have shown that Cu(U) complexes are 
effective m reducing the inflammation associated with RA. Reports 
abound in the literature concermng the active role of copper 
complexes in the control of inflammatory diseases. 22 A great deal is 
known about the role of copper complexation in enhancing the 
pharmacologica.l profile of NSAID activity and reducing toxicity.22 
Other pharmacological activities of copper complexes, and their 
potential as antiarthritic, antiulcer, anticancer drugs have been 
reported. 22 Tnese activities of copper complexes support the 
hypothesis that the corresponding disease is, in part, inflammatory, 
and emphasize the need for more research in the area of essential 
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2.2 Aim. of Study and Objective 
Both Cu(II) and dic10fenac are used to alleviate the inflammation 
associated with RA. It has been postulated that a combination of the 
two agents will have a synergistic effect. That is, their combination 
would be more effective than when these components are 
administered injependently. If this is true there must be some 
chemical reason for the synergism and should be related to the 
thermodynamic stability of the system. 
The aim of this investigation then is to test the synergism hypothesis 
and to elaborate any underlying chemical basis for it by: (i) 
determining the thermodynamic stability of the Cu(II)-DCL system. (ii) 
The determinec formation constants will be used in computer models 
of intestinal fluids and blood plasma in order to investigate the 
speciation of the two components in these biological fluids. In this way 
we hope to demonstrate the existence or otherwise of the Cu(II)-DCL 
complex in solution. (iii) UV jVis spectroscopy will be used to predict 
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2.3 Dissertation Outline 
Chapter 1 (Intnduction) gives an overview of the nature of rheumatoid 
arthritis and its therapy. Chapter 2 (Motivational Study) focuses on 
the effectivene!".s of the drug diclofenac (as well as its encapsulation in 
cyclodextrins) and copper activity in the treatment of arthritis. This 
culminates in formulation of the aim of the study, namely to 
investigate the hypothesis of Cu-DCL synergy. Chapter 3 deals with 
theory and practical application of glass electrode potentiometry. 
Under Experimental Potentiometry sufficient detail of the 
instrumentation used and the preparation of the solutions is given 
followed by the description of titrations and data analyses. Results 
and discussion follow at the end of the chapter. In Chapter 4 
(Spectrophotometry) attempts to deduce structural information from 
absorption spectra and the species distribution of Cu-DCL complexes 
as a function of pH have been made. The severe problem of 
insolubility encountered complicated the study but the methods 
employed to attempt to overcome this (use of cyclodextrin and 
MeOH/H20) were well-founded. The complexes found were then used 
in computer models of intestinal fluids and blood plasma to calculate 
the speciation of the two components. Chapter 5 (Conclusion) gives a 
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3.1 Theory 
3. L 1 Introduction. 
The glass electrode is to potentiometry what the silicon chip is to 
computers the central component. 1 The glass electrode is dependent 
upon supporting instrumentation such as voltmeters and reference 
electrodes. It is equally possible to use glass electrodes to measure 
hydrogen ion concentrations, expressed as [H+], or activities, 
expressed as pH. In 1875 Lord Kelvin suggested that glass was an 
electrolytic conductor and later in 1906 Cremer reported an Electro-
Motive-Force (emf) across a thin glass membrane separating two 
aqueous solutJOns and noted that this glass electrode potential was 
sensitive to changes in acidity. Ideally, glass membranes ought to 
show a perfect Nernstian response to pH.l 
It is well knov'11 that no glass gives a true response; not only Eo but 
also the Nernstian slope tend to be variable and so each electrode has 
to be calibrated either using buffers to read pH or using standard acid 
and alkali sdutions to read [H+]. Both the glass and reference 
electrodes req-Jire filling solutions, which over the decades potassium 
chloride (KCI) has evolved as the usual first choice because it seems to 
satisfy most of the criteria, especially that of the diffusion rates of 
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pH measurement using an electrochemical cell, therefore, requires two 
electrodes,l one being the working hydrogen - ion activity- sensitive 
electrode and the other a hydrogen- ion activity- insensitive electrode. 
There is a reference electrode that embodies an internal electrode 
such as Ag/ AgCI cell (Ag/ AgCI electrode being inside the glass 
membrane and provides a constant potentia12) and an electrolytic 
solution contained in a glass/ polymer salt bridge, which surrounds 
the internal electrodes and makes electrical contact with the test 
solution through the liquid junction. The only potential which can 
vary is that existing between the outer surface of the glass bulb and 
the test soluticn in which it is immersed, and so the overall potential 
of the electrode is governed by the hydrogen ion concentration of the 
test solution. 
To measure the hydrogen ion concentration of a solution the glass 
electrode must be combined with a reference electrode, for which 
purpose the saturated calomel electrode is most commonly used, thus 
giving the cell: 2 
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3.1.2 Potentiometric Titration 
PotentiometJy3 is one of the most convenient and successful 
techniques fomployed by metal complex equilibrium measurements. 
With metal electrodes it is usually sufficient to use the highly 
accurate glass electrode for measuring the hydrogen ion 
concentration in a procedure termed potentiometric titration. In 
this, for example, standard base is added in increments to a well 
characterised acid solution of the ligand in the absence of and in 
the presence of known metal ion concentrations. While there are 
many other methods for measuring equilibrium constants e.g. IOn 
exchange, NMR, polarography etc, their use is usually invoked 
under spec:.al circumstances, which arise when potentiometry or 
spectrophotometry cannot be employed. Potentiometry does not 
provide microscopic information involving identification of 
protonation and metal coordination sites on a ligand. For such 
information spectroscopic measurement or spectrophotometric 
absorbance studies are needed. 3 
As we have said earlier, this procedure is concerned with changes in 
electrode potential rather than in an accurate value for the electrode 
potential with a given solution, and under these circumstances the 
effect of the liquid junction potential may be ignored. 2 The change in 











Chapter Three ___ . Glass Electrode Poten=ti=o.=-:m:::.e;::..;t=ry-,--_~_-,P,-,a=<g:::o.:e=-=2,-,-4 
Generally speaking the end point of a titration can be most easily flxed 
by examination of the titration curve including the derivative curves to 
which this give:, rise or by examining a Gran's plot. 2 
3.1.3 Titrimetry Analysis 
This refers t,) quantitative chemical analysis carried out by 
determining the volume of a solution of accurately known 
concentration which is required to react quantitatively with a 
measured volume of a solution of the substance to be determined. 
When measurements are made the filling hole of the electrode must be 
left open to the atmosphere; otherwise the flow of liquid through the 
liquid junction will stop.l A slow leakage through the junction is 
needed in order to maintain electrical contact with the surrounding 
solution. 
The liquid jun~tion is an important feature of the reference electrode. 
For storage periods of long duration the glass electrode should be 
stored dry and before using it again it must be soaked. 1 The reference 
electrode should also be stored dry and sealed or with its tip 
immersed in a salt- bridge solution. For short-term storage, i.e. 
between titrations, or overnight, it is important to keep the surface 
layer on the glass intact. Electrodes that are not customarily taken to 
the acid end of the pH scale should be dipped occasionally in mildly 
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Reference electrodes should not be stored in distilled water or weak 
solutions as this can lead to dilution of the filling solution. Whenever 
the electrode is stored for more than an hour or so, it is important to 
ensure that it is placed in a vessel in which the electrode stern and 
vessel are closely joined. This prevents evaporation of the storage 
solution and thus prevents the formation of a crust of salt on a tip of 
the electrode. 1 Electrodes are invariably washed as part of the 
transference procedure from one solution to another. This is 
conveniently cone by giving them three large drenchings with 
deionised wate:- and then blotting them dry with tissues. Water used 
in all electrode manipulations and solutions should be of good quality 
and glass distilled. 1 
When a metal M is immersed in a solution containing its own ions Mn+ 
then an electrode potential is established the value of which is given 
by the Nernst equation:2 
E = E9 +(RT / nF) log amn + 
where E8 is a constant, the standard electrode potential of the metal. 
E can be measured by combining the electrode with the reference 
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It follows that knowing the potential Er of the reference electrode, we 
can deduce the value of the electrode potential E and provided the 
standard electrode potential Ee of the given metal is known, we can 
then proceed to calculate the metal ion activity amn + in the solution. 
For a dilute solution the measured ionic activity will be virtually the 
same as the ionic concentration and for stronger solutions, given the 
value of the activity coefficient, we can convert the measured ionic 
activity into thE' corresponding concentration.2 
3.1.4 Reaction Mixture 
The reaction solution is made up in a cell having features as the 
glass electrocle to hydrogen ion activity, a reference electrode that is 
intended to be the constant potential. 4 The temperature is 
controlled by circulation of thermostated water through the jacket. 
The solutior:. must be completely sealed from the atmosphere 
through the use of O-rings. The cap may be machined plastic with 
grooves for:he O-rings seals. The inert gas must be purified to 
remove C02 and 02 and humidified with a background electrolyte. 
The standard basel acid is added through a capillary tip beneath 
the surface of the solution and is measured by a piston-type burette 
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There should be a sufficient number of openings in the cap to take 
care of the elc'ctrodes and all materials introduced into the reaction 
mixture. The reaction solution can be made up by adding precisely 
measured volumes of ligand solution, standard acid if needed, metal 
ion solution ~hen appropriate. Sufficient solid supporting electrolyte 
must also be added to provide the ionic strength desired for the 
electrolyte, metal salt and ligand contributions to the ionic strength 
(1).4 There are several salts used to keep the I of a test solution 
constant. The kind of salt selected for the purpose must such that it 
dissolves to yield ions that are common to the reacting acid and 
base, so as to eliminate the introduction of other factors of 
variation. 1 Doubly distilled water may then be added to make up the 
volume exactly to the pre-determined amount. 4 
3.1.5 Calibration of the Electrode 
Prior to making measurements on the experimental solutions, it is 
necessary to calibrate the pH meter and electrode system in terms of 
hydrogen ion concentration.3 The glass electrode has an asymmetry 
potential which makes it impossible to relate a measured electrode 
potential directly to the pH of the solution and makes it necessary to 
calibrate the electrode. 2 The slope of the electrode is determined 
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The Nernst equation shows that the glass electrode potential for the 
given pH values will be dependent upon the temperature of the 
solution. In this case a buffer line is obtained by plotting the observed 
emf for each buffer against the pH.s The slope of this line gives the 
value of s, for the electrode: 
The acceptable working range of the electrode response slope at 
25°C is: 58.60 < s 59.16 
This method is adequate if only relative measures of the hydrogen ion 
concentration are required. 5 More precise calibration may be achieved 
by plotting the hydrogen ion concentration observed at each point of a 
strong acid strong base titration performed at constant ionic 
strength against the observed emf. The most suitable pH regions for 
glass electrode calibration are 2.3 to 2.9 in the acid region and 10.8 to 
11.3 in the alkaline region. S 
3.1.6 The PotEntiometric Cell 
Immersed in the test solution are two "electrodes", more precisely 
described as the probes for the species being monitored and a liquid 
junction J leading to a reference half-cell via a salt bridge. 6 The cell 
can be written as: 
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The Nernst equation for electrode response can then be expressed in 
terms of concentrations rather than activities. The emf of cell 1 is 
given by: 
Eccll = Ep Eref + EJ + Ej ............ 2 
where Ep and Ercf are respectively the potentials of the probe and 
reference half cells, and EJ and Ej are the diffusion potentials at 
junctions J and j. Many probes respond to the concentration of a 
single species S according to the relationship: 6 
Ep = EpO + !l.sRT?·l In [SJ ............. 3 
where Ep ° ane 'As are constants. Since values of Eref and are 
unaffected by changes in the test solution, the emf of cell 1 can be 
\vritten as: 
Ecell = EO + AsRTF-l In [S] + EJ ............. .4 
where the value of 
EO Ep ° + Eref + Ej ............. 5 
is constant. It is often convenient to combine EO and EJ to give 
Eo'const = EO + E] ................ 6 
which will also be constant provided that EJ does not vary. If this 
condition is fulfilled equation 4 becomes 
Ecell == EO'const + AsRTF-l In is] 
The temperature of the cell has to be kept constant so that the slope 
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3.1 Ligand Reaction Equations. 
InteresF in the determination of stability constants of metal ion 
complexes was greatly stimulated by the work of J.Bjerrum who 
elaborated a general method for the determination and calculation of 
the stability constants for metal ammine complexes. It was shown that 
unidentate ligcmds invariably are added in a succession of steps, 
which can be represented as: 7 
MLn-l + L B MLn 
in which8 the species MLn is formed by the addition of one ligand to 
the preceding complex MLn-l. 
Similarly, in the usual case, where the preceding complex MLn-l can 
also exist, the activity of MLn can be expressed in terms of the 
activities of MLn-l and L.9 Thus: 
{MLn} = Tf3n {M}{L}n = TKn{MLn-l}{A} 
where the overall stability constant Tf3n is the activity quotient for the 
reaction step 
M + nLB MLn 
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Moreover, the overall and step stability constants are related by the 
expression9 
n 
pn = KIK2K3 ... Kn = n Kn 
1 
The numerical values of the stability constants of a gIVen complex 
depend not only on the experimental conditions employed but also on 
the units in whlch the activity terms are expressed. 9 
n 
nKn indicates H ' the product of all the stepwise stability constants up 
to the nth step. In the absence of the metal ions, the protonation 
constants of a ligand in the chemical equation: L + rH B LHr 
May be expressed as the overall stability constant: p = [LHrlj[L][HJr 
or as in the ste pwise formation: 
LHr-l + H B LHr 
As the stepwise stability constant: 
K = [LHr]j [LHr-][H] 
The relationship between these two kinds of constants is: 
r 
p =n KH,i 
1 
indicating the accumulation of the stepwise stability constants, where 
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3.1.8 The Ionic Strength. 
The concept9 of ionic strength was introduced in 1921 by Lewis and 
Randall, who stated that in dilute solutions, the activity coefficient of a 
given strong electrolyte is the same in all solutions of the same ionic 
strength. A theoretical relationship between the activity coefficient and 
the ionic strength was derived by Debye and Huckel in 1923, and 
since then many workers have attempted to keep activity coefficients 
constant by usmg solutions of constant ionic strength.9 
Although it is sufficiently accurate at low ionic strength to choose 
some form of the extended Debye-Huckel equation for the calculation 
of activity coefficients, it is better at higher concentrations to 
determine the most appropriate parameter values. lI For ions it also 
varies with the ionic charge, and is the same for all dilute solutions 
having the same ionic strength, the latter being a measure of an 
electrical field existing in the solution. The term ionic strength 
designated by the symbol I, is defined as equal to one half of the sum 
of the products of the concentration of each ion multiplied by the 
square of each charge number or: 1:= 0.5 I Ci Zi2 where Cj is the ionic 
concentration in mole per litre of solution and Zi is the charge number 
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It can be shown on the basis of the Debye~Huckel theory that for 
aqueous solutions at room temperatures: 
Log Yi = -0.509 Zi2 (Ijmolkg-1)o.5 
where Yi is the activity coefficient of the ion; Zi is the charge of the ion 
concerned, I is the ionic strength of the solution.37 
3.1.9 Stability Constants. 
A large and very important group of equilibria is that which involve 
the formation of complexes between a metal ion and various Lewis 
bases known as ligands. A wide variety of anions and molecules can 
act as ligands usually by donating an electron pair to the metal ion to 
form a sigma bond.8 
Although almost any metal ion, given a suitable ligand, can act as the 
central group of a complex, some form complexes more readily than 
others. In aqueous solution a metal ion becomes surrounded by a 
number of other ions or small neutral molecules, for example, water 
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The aggregate consisting of a metal ion together with its collection of 
followers is called a metal ion. Following Rossotti & Rossotti,13 a 
complex can be' defined as a species formed by association of two or 
more simple species, each normally capable of independent existence. 
The stability of a complex may be expressed quantitatively in terms of 
one of its stability constants. 9 If the two species M and L coexist in 
solution, they may react to form one or more complexes of general 
formula MLn where the species M comprises the central atom to which 
the species L, usually referred to as a Ligand, is coordinated. We can 
generalize these reactions for simplicity as follows: 13 
M + nL ~ MLr .................. 1 
Polynuclear complexes 13, MpLqHr (for which p > 1, q ~O, r ~O), are 
frequently encountered in aqueous solution chemistry, particUlarly in 
hydrolysis reactions where L = OH-l. The ligand L may be 
monodentate, bidentate or polydentate, i.e" it may coordinate using 
one, two or more donor atoms. 9 Ions of metals towards the end of the 
d-transition series form a wide variety of stable complexes with 
ligands, which contain nitrogen atoms. Some ligands contain more 
than one donor atom, and so can be attached to the metal ion at more 
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They act as chelating agents, with two donor atoms clipping on to the 
metal ion like the two pincers of a crab's claw. The number of ligands 
which can bind a central metal ion naturally depends on the number 
of donor atoms which are used by each ligand group and by the 
preferred stereochemistry and relative sizes of both ligand and metal 
ion. 8 Stability constants, or equilibrium constants for metal complex 
formation, have long been employed as an effective measure of the 
affinity of a ligand for metal ions in a solution, and have served as a 
quantitative indication of the success or failure of the ligand design.3 
By 1953, stability constants for a number of metal complexes had 
been reported and it was feasible to ask the following questions: 13 
1. for a given ligand, how does the stability constant vary with 
changes in the central metal ion? 
2. how does the stability vary when the nature of the coordinating 
ligand, L, is changed? 
After reviewing all the data, Irving and Williams showed that for 
divalent ions of the first transition series the stability always follows 
the order: Mn <Fe <Co <Ni <Cu <Zn. For each cation the stability 
increased when donor oxygen was replaced by donor nitrogen in either 
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As the number of chelated rings increased so the stability increased, 
but it decreased with increase in ring size. The order of decreasing 
stability F-» CI- >Br- >I- was followed by most cations (Group (il)' but 
was reversed for a few elements such as Ag+, Cu+, Hg2+, T13+ for which 
the stability increased in the order F- < CI- < Br < 1-. 13 
3.2 Copper-Glycine Complex. 
3.2.1 Introduction. 
Glycine (H2N-Crb-COOH) IS the simplest a-amino carboxylic acid for 
which the side chain is H.17 But it never occurs to an appreciable 
extent in this form.14 Like all the amino acids in their pure states, it 
exists as a dipolar ion, a zwitterionic form being more favoured 
energetically both in solution and in the solid state. 14 Glycinate ion 
(gly-) is a bidentate ligand (literally two teeth), 15 because it bonds to a 
metal using an electron (e-) pair on each of the nitrogen and the 
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Amino acetic aCld (glycine»»»»»»>glycine dipolar ionic form 
This ligand can bond two different donor atoms to the one metal atom 
and this can lead to unsymmetrical arrangements of ligand groups 






Figure 3. The glycinato chelate ring 
The fully protonated glycine cation, [H2L]+, contains two ionisable H 
IOns, which dissociate stepwise in fully separated processes. 
Depending on the pH of is solution, glycine can exist in three different 
forms: the catLOnic [H2LJ+, the zwitterionic [HLJ± and the anionic L-
forms. Since the dissociation steps are well separated, the 
concentration of the neutral form HL is negligible. Besides these 
monomeric pre,ton complexes, various polymeric associates e.g. [H2Lj-, 
H2L2 and [H3L:d+' can also be formed in concentrated solution. 15 The 
mam reason for the association of the monomeric species is the 
formation of H-bonds between them, whereas in dilute aqueous 
solution the monomeric species are stabilized through H-bonds with 
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3.2.2 Presentation of equilibrium data. 
The proton complex formation constants of glycine are expressed as 
stepwise protonation constants. For the equilibria 
H+ + L- == HL (protonation of -NH2 group) and .......... 3 
H+ +HL == H2L (protonation of -COO- group) ............ .4 
the constant Kl relates to the first processes and K2 to the second: 
Kl == [HL1_ 
[H+][L-] 
3.2.3 Metal complex stability constants. 
Cu (AA)n complexes (AA == amino acid) have already been the subject of 
detailed investigations in solution. 18 Complexation constants of 
different AA wIth Cu2+ were determined. 19,20 The type of binding 
between an AA and Cu2+ is the same for all a-amino acids with the 
exception of histidine. 21 Of the metal complexes, those of the 3d 
transition metal ion especially Cu(II) have been studied in most 
detail. I4 
In order to validate the experimental procedure and method, this 
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3.3 Experimental Potentiometry 
3.3.1 Instrumentation and Chemicals. 
Potentiometer PHM 84 RESEARCH pH METER 
Burette DOSIMAT 665 Automatic Burette 
Electrodes Q Metrohm 6.0133.100 & 6.0726.100 (ref.) 
pH 0 ... 14 / 0 ... 80"C 
Ref. Ag, AgCl, 3M KCl 
Acid O.lM HCl 
Base O.lM NaOH 
Background Electrolyte 0.15M NaCl 
All the titrations were automatically controlled. The electrometric cell 
in which the metal-ligand interactions were studied consisted of a 
jacketed beaker equipped with magnetic stirrer and fitted with a tight-
fitting rubber stopper through which were inserted an inlet and an 
outlet tube for nitrogen gas, a glass and a reference extension 
electrode. There is also an opening for the materials introduced in the 
reaction vessel like the addition of the standardised acid and base for 
titration in the solution. 
The magnetic stirrer that was used allows a homogenous solution to 
be obtained giving a fairly fast response time but all calibration 
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Care should be taken to ensure that the stirrer does not heat the 
solution. Also, the magnetic follower does not bump when rotating 
and thereby damage the electrodes. 
3.3.2 Preparation of Solutions. 
The experimental solutions m the cell were each maintained 
constant at ~~soC by the circulation of the thermostated water from 
a mercury contact thermoregulator controlled water bath through 
the jacketed cell. The ionic strength of all solutions were 
maintained at O.ISM using NaCI as the background electrolyte. 
3.3.2.1 Acid Solution (HCl) 
These were made from O.IM BDH CVX ampoules on the SOOml 
volumetric flask. After preparation was complete standardisation 
against recrystallised borax was done. 
3.3.2.2 Base Solution (NaOH). 
NaOH solutions were also made from BDH CONVOL ampoules in a 
SOOml volumetric flask to make a O.IM solution. The presence of 
carbonate in the NaOH was checked using the method of May et 
al. 36 Because the solution must be C02 free N2 gas was pumped 












Standardisation of the base solution was carried out against 
recrystallized KHP (potassium hydrogen phosphate). 
3.3.2.3 Solutions of ligands. 
Solutions of glycine and dic10fenac were freshly prepared using high 
purity samples obtained from Sigma -Aldrich Co. and they were 
standardised potentiometrically. For each titration the required 
amounts of the ligand were weighed out and were allowed to 
dissolve in the experimental cell under N2 atmosphere. 
3.3.2.4 Solution of the Cu (II) Metal ion. 
Stock solution of Cu (II) ion was prepared by dissolving the required 
quantities of the respective chlorides (reagent grade) in double 
distilled water and standardised by complexometric titrations. 
3.3.3 Calibration of Electrodes. 
Prior to caLbration the electrode was stored overnight in a O.lM 
HCI solution. It was repeatedly rinsed with distilled water and 
patted dry with soft tissue paper. It was blotted dry and not wiped 
in order to minimise the build up of static electricity. The slope of 
the electrode was checked using standard buffers. The emf reading 
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3.3.4 TitratioLs. 
3.3.4.1 Glycine Protonation Titration. 
An approximate amount of the background electrolyte NaCI 
solution was dispensed into the titration vessel having the weighed 
out ligand fonowed by small addition of the required concentration 
of the standardised HCI solution from another burette. This volume 
of HCl solution was added to the vessel to ensure that the ligand 
was completely protonated. The electrodes completed the reaction 
cell and the solution was allowed to stand until the working 
temperature had been attained and all the ligand had dissolved. 
Potentiometric titration was followed with the glass electrode at base 
increments of NaOH. Data obtained consisted of the volume of base 
added and the corresponding emf values of the system at each 
titration point. This was used in the data analyses discussed below. 
3.3.4.2 Diclofenac protonation Constants Titration. 
Diclofenac is insoluble in water and precipitates at low pH values, so 
the sodium salt was titrated from high to low pH until precipitation 
occurred. The insolubility of diclofenac forced us to employ two 
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Previous work reported that diclofenac is highly soluble in organic 
solvents including methanol so a 50% v Iv solution of methanol in 
water was used in one method to dissolve the ligand. Another method 
employed was f3-CD, which has the ability to encapsulate drug 
molecules. In o::hese titrations f3-CD and diclofenac were weighed 
directly into the titration vessel to give 20ml of a O.OlM and 
approximately 8 x lOA M solution of f3-CD and diclofenac respectively. 
Both titrations for the two methods used were carried out with 
increments of HCI. 
It has been observed that in the range between 8.2 and 12.7 pH units, 
the electrodes' response is practically constant and independent of pH 
because diclofenac was completely ionised in this pH zone. In the pH 
zones <8.2, there was a precipitation of diclofenac in the form of acid, 
by protonation )f the secondary amine. Also the interference from the 
H+ ion causes an oscillation in potential. 
Considering this behaviour an acidic solution was employed 
throughout the investigation process. For diclofenac it became 
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3.3.5 Data Analysis. 
For glycine, the concentrations of both acid and ligand were used as 
input into an ESTA file template for the determination of the 
protonation constants. ESTA is used for simulating simple equilibrium 
distributions of chemical species. The major objective in ESTA is to 
provide a flexible tool for investigating phenomena associated ,-'lith 
chemical interactions in solution and for their quantitative 
characteristics. 36 Also ESTA program being the refinement of stability 
constants from potentiometric data measured on protonation and 
complexation systems containing any number of interacting 
components. Whilst the situation is different for diclofenac, the 
concentration of ligand was then used as input into an ESTA file 
template for the determination of the protonation constants. 
These results were then used to generate ZH curves. It should be noted 
that, before aey good agreement obtained, several adjustments to 
experimental:::oncentrations were necessary. Several different 
titrations were performed, each with slightly different initial 
concentrations of ligand. 
3.3.5.1 Metal ion Complexation Titration. 
These were also done under an inert N2 atmosphere where the mole 
ratio of the metal to ligand was varied. For diclofenac, weighed 
amounts of the ligand were put in the reaction vessel together with 
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For the second method, weighed amounts of diclofenac dissolved in 
50% MeOH/fbO and then addition of Cu2+ were put in the reaction 
vessel and the titration for metal ion complexation run with 
increments of acid. The water used to make the 50% MeOHjH20 
solution had an ionic strength of 0.15M (NaCI). For glycine, 
although enough acid was added to raise the pH to the relevant pH 
range the initial volume in the reaction vessel for glycine was held 
constant for all of the experiments. Also the metal ion was added 
from another burette in small ranges and the titration proceeded 
by base increments of NaOH. 
3.3.5.2 Complexometric Titration Data Analysis. 
The titration data for each of the pairs of titrations carried out at 
different metal: ligand ratios were first analysed separately as pairs 
and then all together as a whole. In each case the input data i.e. 
protonation constants determined as outlined above, the calculated 
concentrations of the metal, ligand and hydrogen ion were included. 
Also the electrode potential calculated from a strong acid reading 
taken immediately prior to the titration and the dissociation constants 
of water and methanol was included. 
Even v,lith this task the calculated and observed plots must completely 
overlap if the model is correct. It should be said that the accuracy that 
is needed for potentiometric work is a skill that is acquired with wider 
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The results m the following section are from sets of repetitive 
experiments. 
3.4 Results. 
In order to validate the experimental procedure, the known system of 
Cu/glycine was studied and results compared to literature (Table 3) 
Table 3. The logarithms of the stability constants measured for the Cum} 
glycinate system MpLqHr at 25'C, 1=0.15 M Rf = Hamilton R factor, 




19Stability constants measured at 25'C, 1=0.15 M KCl 
Table 4. The loqarithms of the stability constants measured for the 
Cu(IIJ-DCL system MpLgHr at 25'C, I =0.15 M. {3CD = {3-Cyclodextrin, 
Met Methanol, Rf = Hamilton R factor, Rlim = Hamilton R limit a = 
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3.5 Discussion. 
The protonation and metal ZBAR curves for glycine are given in Figure 
4 and 5 respectively. As can be seen there is a good agreement 
between titrations under different conditions. For glycine, a statistical 
analysis of the results indicates that there is a good fit between the 
theoretical model and the experimental data (see Table 3 above). In 
addition there is a good agreement with the literature. The largest 
error is 0.12 log units which is acceptable. 
FiglJre 4. ZBAR curves for glycine titrations at 2S0 C and I=O.lSM( NaCl). 
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Figure 5. ZBAR curves for Cu-Glycine titrations at 25° C and I =O.15M 
(NaCl). The ratio ofM:L ratio given with total cone. of Gly 
2 X 
1.5 
• 1:2 0.01005 M 1:3 0.00989 M 
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Potentiometric measurements were performed for the determination of 
the protonation constant of sodium diclofenac and complexation of the 
ligand. As DCL is insoluble in acid medium, the normal procedure of 
titrating with base from low to high pH could not be used. Instead, the 
ligand was dissolved in base and then titrated with acid. As soon as 
precipitation was observable or the electrode response became 
unstable the titra tion was stopped. Generally the electrode response 
became unstable before precipitation could be clearly seen. A ZBAR 
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Figure 6. ZBAR curves for Diclofenac (a.aaa8M) titrations at 25· C 
and 1= a.1SM (NaCl) 
+ 0.OO08M 
6 7 8 9 10 11 
pH 
As can be seen the maximum ZBAR value was 0, which is too low for a 
meaningful detennination of its protonation constant. One possible 
way of overcoming the problem of precipitation was to work at lower 
concentrations. However, the final concentration was 8 xlO-4 M, which 
was near the limit for our experimental set-up. 
Because of the difficulties of precipitation the experiments were 
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Microencapsulation of drug molecules in CDs has been used 
extensively in the pharmaceutical industry to produce more soluble 
drug preparations with improved bioavailability. The results for the 
titration of DCL in the presence of I3-CD are given in Figure 7. These 
results show that protonation of DCL is indeed occurring and a ZBAR 
value of 0 .15 is attained before precipitation occurs. This happens at 
pH -5. 
Figure 7. ZBAR curves for 8CD (a.a1M)-DCL titrations at 2S"C 
and 1= a.1SM (NaCl), the conc. ofDCL given. 
0.2 
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0 . 16 
0.14 
















. 0.000775" DCL 
. 0 . 000755" DCL 
- • 6.S 7 
A 100-fold excess of I3-CD was used so that, under these conditions, 
the DCL was assumed to be fully encapsulated. The results of the 
ESTA analysis of the data are given in Table 4, a value of 4.3 being 
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This result is different to that obtained by J.A Arancibia27 in his 
studies where a value of 4.9 was obtained under the same conditions. 
However the value of 4.3 seems more reasonable when compared to 
literature values of analogous compounds such as phenyl acetic acid 
(pKa =4.1, t=2SoC and 11= 0.1M)24 and also acetic acid (pKa =4.53, 
t=37°C and 11= 0.15M). J.A Arancibia27 also managed to measure an 
equilibrium constant of 104 .8 for DCL in aqueous solution but under 
their conditions precipitation was observed by us. 
The agreement between the results in 13-CD and pure water led J.A 
Arancibia27 to postulate that the dichlorophenyl end of the DCL is 
really included in the 13-CD cavity and that the carboxylate group does 
not interact wi':h 13-CD cavity. 
However crystal structure of this inclusion complex does not support 
this conclusion.29 These studies show interactions in both hydrogen 
bonding and hydrophobic interactions between the phenylacetic 
residue of DeL anion and 13-CD. Hence the phenyl ring is fully 
inserted in thE 13-CD cavity while one carboxylate 02 atom is hydrogen 
bonded to a primary OH group of the 13-CD molecule. In the crystal 
structure, the bulky dichlorophenyl group is not in the 13-CD cavity 
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The CI substituents are shifted away from the middle of f3-CD where 
they can no longer fit inside it and therefore protrude slightly.34 Also, 
E .J .Moyo28 in her studies postulated that the ligand can go into the 
cavity from the wider side with the phenyl ring (B) going in partly to 
leave the CI atoms just standing out (see Figure 8 below). It has been 
reported that th e ionised forms of the drug molecules are both more 
hydrophilic and carry a larger number of the tightly bound water 
molecules than the unionized forms .33 The water molecules are 
located outside the cyclodextrin cavity, which stabilises the crystal 
structure. This alone also justifies that it is hard for the chlorine 
atoms to enter the narrow and relatively lipophilic CD cavity.33 
Figure 8. Cyclodextrin inclusion ofDiclofenac 
But the problem encountered when f3-CD was used, was the working 
pH range, wh ich was only pH 5-7. Below pH 4.5 the electrode 
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Because of this, another method of improving the solubility of the 
ligand was tried. DCL is highly soluble in organic medium so a 50% 
MeOH\H20 was used as the solvent. In this medium titrations could 
be perfomed in the pH range 3-6 before precipitation occurred. Figure 
9 below shows the ZBAR plot for this system with the protonation 
constant given in Table 4. Under these conditions, reproducible 
titrations were possible with a ZBAR value of 1 being attained. 
Figure 9. ZBAR curves for DCL in SO%MeOH\H20 at 2S"C 
and 1= O.lSM NaCl, the cone. ofDCL given. 
1 
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The results in Table 4 show that the Hamilton Rf values and standard 
deviation in 50% MeOH\H20 are quite low. Hamilton Rr is an estimate 
of the goodness of fit between experimental emf and the calculated 
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The Hamilton Rlim is the lowest possible R-value that is statistically 
significant given the random errors in the experiment. The agreement 
between Rlim and Rf indicates that the model cannot be statistically 
improved. As can be seen the reproducibility of the titrations were 
excellent and indicate a well-behaved system. 
At 50% MeOH\H20, a pKa value of 4.82 was obtained for the 
carboxylic acid. Similarly, C. J. Byrne31 and R. G. Bates32 , obtained 
protonation constant values of 5.47 and 5.54 for phenylacetic acid 
and acetic aciC. respectively under the same conditions. These values 
are slightly higher than the 4.82 obtained for DCL in this study. The 
most likely reason for this sequence of the stability: acetic acid> 
phenylacetic add> DCL, is the inductive effect of the phenyl ring. 
Although NSATDs are very widely used, they are well known for 
causing gastromtestinal ulceration and bleeding. So complexation of 
these drugs with CDs was a possible way of reducing irritation by 
promoting more rapid absorption and therefore shorter exposure to 
the drug.34 Bu- because of the smaller working pH zone (pH<4.5) the 
complexation titrations were not possible with ~-CD medium as the 
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The titrations for the complexation of the metal ion were then carried 
out in methanol medium. The experiments were carried out using acid 
increments as investigated earlier so at approximately pH 6.2 the 
ligand is fully protonated. But at pH -5.7 one proton from the 
protonated carboxylic group is released into the solution due to 
complexation and a 1 1 0 species formed. 
Below pH 5.7 as seen in Figure 11 below, this formed speCIes 
accumulates in the solution and a slight levelling off of the plot up to 
pH 4.9 shows this accumulation. At pH 3.9 another species is formed 
due to the dep:-otonation of the 1 1 0 species, which is indicated in 
Figure 10 below by the fanning back of the curve. After pH 3.1 the 
ligand precipitated out of solution as shown by the sudden drop /fa11 
in of the plot as seen in QBAR curves and all the titrations done were 
terminated in this region. 
Since the ligancl has no other dissociation protons deprotonation must 
be occurring at one of the coordinated water molecules. However the 
pKa for formation of this species is 6.5 (IOg!311-1 - log!311 0), which is 
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Figure 10. ZBAR curves for Cu(O.OOlM)-MetDCL at 25°C and 1= O.lSM 
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Figure11. Both GBAR and n-bar (boldline) curves for Cu-MetDCL 
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The results of the ESTA analysis are shown in Table 4. A value of 3.5 
is obtained for log ~JlO and it can be compared to a value of a log ~11O 
2.7 obtained for Cu/acetic acid in 50% MEOH and also a log ~11O 2.59 
for Cu/phenylacetic acid under the same conditions.3o The CuDCL 
complex is a factor of 10 x more stable than the analogous carboxylic 
acids. 
The difference in stability cannot be explained by a difference in the 
basicity of the acid as all three acids have very similar pKa's. In fact 
acetic and phenylacetic acid have higher pKa's. We would therefore 
postulate that the increased stability of the copper complex of DCL 
results from an involvement of the amine group. Metal ion 
coordination to both the carboxylate oxygen and the amine would 
result in a seven membered chelate ring. This would increase the 
stability of the complex. However because of the two phenyl 
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Spectrophotometry, the measurement of the intensity of light 
absorption in a particular spectral region, is widely applicable, and is 
especially useful when substances in liquid medium has a strong 
characteristic absorption in a conveniently accessible region of the 
spectrum. l 
The formation of a metal complex is often accompanied by a change in 
the light absorption of the complex relative to that of the individual 
metal ion or ligand. 2 A change in the visible spectrum is often 
attributed to the formation of inner-sphere complexes, whereas 
changes in the charge-transfer UV. region is associated "vith outer-
sphere interaction or ion-pair formation. Changes in the ultraviolet 
region however may also reflect the presence of species formed in less 
close interactions and so the method is in principle, capable of 
distinguishing <')etween outer- and inner-sphere ion-pairs (only if both 
regions can be theoretically be observed).2 
In purely practical terms, the most important use of electronic 
spectroscopy ill the UV and visible regions is in identification and 
quantitative rr:easurement of certain transition metal complexes, 
which usually have bands of characteristic frequency and intensity in 
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Copper(II} is the most stable form of copper in aqueous solutions in its 
d9 configuration which gives rise to Jahn-Teller distortions both m 
simple compounds and in complexes. 4 A wide range of 
stereochemistries is exhibited by Cu(II) compounds, with hexa-, penta-
, and tetra-coordinate species. In aqueous solution, hexa-coordination 
is always attained by coordination of water molecules. 4 
Because of the Jahn-Teller effect, hexacoordinate Cu(II) speCIes are 
always apprec:ably distorted with respect to the regular octahedral 
structure. The tetragonally distorted octahedral complexes of Cu(II) 
are blue or green, the blue aquo-ion being formed when Cu(II) salts 
are dissolved in an excess of water. It is tetragonally distorted, with 
two water molecules further away from copper than the other four, 
which are in a square plane around the metal. 4 A broad absorption in 
the 500-900 mp region of the spectrum appears which is due to 
overlapping d-d bands. The intense bands in the UV region are due to 
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4.1.2 Colour and Molecular Structure. 6 
The visible region of the electromagnetic spectrum is defined in terms 
of the wavelength range to which the human eye responds. The usual 
range of wavelengths quoted is from 380nm at the violet/blue end to 
780nm at the long wavelength red end of the spectrum. 6 Beyond the 
short waveleng'\:h (violet/blue) end of the visible region there are the 
UV and X-ray regions, and beyond the long wavelength (red) there are 
IR, microwave and radiowave regions. 
The main requirement is knowledge of the range of wavelengths over 
which the analyte solution absorbs. If the solution is coloured then we 
immediately know that it absorbs over the visible range and hence an 
instrument operating over the visible region is probably sufficient for 
structural analysis. 6 
4.1.3 Absorptio:l Spectra with Molecular Structure. 
When molecules interact with radiant energy in the visible and ultra-
violet (UV) regions, the absorption of energy results in the excitation of 
an outer electron in the molecule. Rotational and vibrational modes 
are found combined with electronic transitions. Broadly, the spectrum 
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In reality atoms absorb and emit radiation and have their energy 
levels perturbed by external electric and magnetic fields. 8 As no 
unique electronic spectrum is found, this is a poor region for product 
identification by the fingerprint method.9 On the other hand, 
electronic absorptions are often very intense. Molar absorptivity values 
frequently exceed 10 000 in the UV region, whereas in the IR region 
they rarely exceed 1000. Thus dilute solutions containing complexes 
are more easily measured in visible- UV spectrophotometry.7 
4.1.4 The Absorption Spectra of Transition Metal Complexes. 10 
UV jVisible spectroscopy is useful in analysis of transition metal 
complexes, which absorb characteristically in the visible region of the 
electromagnetic spectrum (ems) .11 Over this range of wavelengths, 
absorbance is measured in an attempt to find the wavelength of 
corresponding to the d-d electronic transitions. 12 
The energy of electronic transition (E =hcjAmax) whereby h: ... , c: ... , 
A: ... depends on the chemical environment of the metal ion and the 
position of Amax will shift either towards longer or shorter wavelengths 
depending on the ligand attached to the metal ion. A shift towards 
longer wavelengths is called bathochromic or red shift and a shift 
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Colour solutions are chromophoric11 and are a result of absorption 
properties therefore the transmittance of light of a colour are 
complementary to the colour of the absorbed light of a certain 
wavelength. 14 Taken over a wider range of wavelengths, the spectra of 
transition metal complexes exhibit metal -ligand (or vice versa) charge 
transfer (LMCT bands at about 200-700nm.1 
The charge transfer bands are generally of very high intensities, which 
cause an elect::-on to move from one descrete transition to another. 
The d-d transitions are characteristic of the transition metal. 
Transitions that are forbidden are between those energy levels that are 
of the same symmetry (g--->g, or u--- >u) or of the same orbital 
angular momentum quantum number (1). Since this is the case in the 
octehedral ligaQd field, the d-d transitions are not strictly allowed. 
They are said to be Laporte-forbidden. 
The transitions are forbidden because electronic transitions have to 
involve a change in parity. Thus transition can only be allowed if the 
symmetry of the molecule is removed. If this is not the case, the 
transitions will be very weak, with an oscillator strength (f) of - 10-4. 
The f is the effective number of electrons that are put into oscillation 
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In the tetrahedral ligand field environment there is no centre of 
symmetry and therefore the orbitals may acquire some p-orbital 
character, so that the forbidden d-d transitions will be partially 
allowed. Distortion from perfect octahedral symmetry increases the 
transition probability and hence the intensity of the transition. This 
lowering of tht symmetry of the molecule could be due to vibration, 
steric strain or an inhomogenous ligand field. l 
When a metal ion contains only one d-electron, it is easier to predict 
the spectra to be expected from each ligand field. This is because the 
electronic distribution in the orbital will be dictated only by the ligand 
strength. HoV\ever, when the metal ion contains more than one 
electron in the d-orbitals, inter-electronic repulsions have to be taken 
into account and this results in different electron spin-angular 
momenta combinations. l 
In such cases, an initial comprehension of the different possible metal 
electronic orbiml filling possibilities in the ground and excited states is 
important. How these will be affected by the symmetry of the resultant 
complex should follow from their initial distribution in the d-orbitals. 
Orgel diagrarrs are useful in showing the nature and energies of 
electronic transitions induced by ligand fields of different strengths 
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When the elecronic nature of the central ion is known, electronic 
spectra with characteristic absorption peaks and intensities can be 
used to suggest the nature of the ligands surrounding the metal ion. IS 
Even though the structural information obtained from the electronic 
absorption spectroscopy is not as complete as that which would be 
obtained by diffraction methods, it does help in the structural 
elucidation of metal complexes especially for those in solution. 
Some transition metals, including Cu(II) have unsymmetrically filled 
d-orbitals. Due to the Jahn-Teller effect the result of this is the 
tendency of the distortion of the octahedral geometry resulting in an 
uneven ligand field symmetry_ These so called Jahn-Teller distortions 
of the regular octahedral coordination geometry can occur by either 
the shortening or lengthening of the axial ligand bond lengths. IS 
This distortion of the ideal octahedral symmetry causes a relaxation in 
the electronic selection rules resulting in more transitions. The energy 
of the absorption, the shapes of the absorption bands and their 
intensities can be very informative, especially when compared to the 
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A metal ion in a biological system encounters various kinds of donor 
atoms that have different ligand field strengths. These can include for 
instance the amino nitrogen, the peptide nitrogen, the imidazole 
nitrogen, the carboxylate oxygen, the peptide oxygen, the water oxygen 
and the hydroxide oxygen.1S The ligand field strength of each of these 
different types of donor atom is further influenced by other factors 
such as the structure of donor molecule, the surrounding biological 
system and the metal that is being complexed at any particular time. 
The energy contributions made by each donor atom to the total energy 
of the electrom c transition of the metal complex can be calculated by a 
method proposed by Billo. 16 This is calculated by the formula: 
E = h Veale, whereby Veale ::: LVi ------1 
where Vi is the contribution of atom i. 
Based on the experimental work on about 34 copper complexes, 
Billo 16 propos,=d the following energy contributions for the different 
types of oxygen and nitrogen donor atoms: 
v(NH3) ::: (4.53 ± 0.07) X10 3 jcm. 
V(H20 or OH-) ::: (3.01 ± 0.03) XI03jcm. 
v(carboxylate) (3.42 ± 0.10) XI03 j cm. 
v(peptide N2) :; (4.85 ± 0.04) XI03 j cm. 
It is understood from this that the effects of the rest of the atoms of 
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4.1.5 The Absorption Spectra of Copper Complexes. 
The chromophoric nature of the Cu(ll) ion is due to its low lying d-
orbitals. 4 The characteristic d-d absorption band which IS in the 
visible region changes its transition levels according to whatever 
ligand field is around it. II The absorption spectra of transition metal 
complexes have been shuwn to be pH dependent. There is normally a 
general hypsochromic shift of the d-d absorption maximum that 
accompanies an increase in pH. This phenomena could be explained 
as an increase in the basicity of the donor atoms or/as well as a 
possible increase in the number of coordinated donor atoms. 12 
The spectra of complexes in solution appear as broad spectral bands 
due to the unresolved rotational and vibrational absorption peaks.I8 
The single band observed in the case of the Cu(II) complexes is 
composed of three absorption bands, corresponding to the following 
electronic state transitions: 12 
2Al g +- 19 
+- 2BIg 
2E1g +- 2BI g 
When surrounded by SIX water molecules, Cu(II) shows maxImum 
absorption at 800nm.12 This maximum IS moved to shorter 
wavelengths of approximately 600nm by the substitution of four of 
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The shift can be explained as follows: the enhanced splitting of the 
degenerate d-orbitals by the stronger ligand field of the nitrogen atoms 
causes the blue shift. The colour of the tetraammine aqueous solution 
is blue. Due to the Jahn - Teller effect, the four metal amine bonds 
are in one plane and they are shorter than the axial metal ligand 
bonds, which je along the z-axis. A fifth ammine group can be added 
at one of these positions but it will be loosely bonded. The sixth 
position is even more weakly coordinated and [Cu (NH3)]62+ only forms 
in liquid ammonia. I? 
The nature 0: electronic transitions that are brought about by a 
chelating ligand can be inferred from general observation of the effect 
of monodentate ligands on the ligand field parameter15 as described in 
Table 5. 16 This shows a guideline that is normally used for the 
estimation of ,:he effect of the ligand field imposed by nitrogen based 
chelating ligands. 
Table 5: The absorption maxima of the Cu(II) am mine complexes 190f the 
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Copper peptide complexes that are similar in structures tends to have 
similar Amax values which implies that the energy of their electronic 
transitions is not significantly different.2o During the formation of 
these complexes the colour changes from blue to purple to red In 
order of the increased number of coordinated nitrogen atoms. 
The general approach to the study of metal complex spectra is by the 
"rule of average environment" .18 According to this rule the ligand field 
in a mixed ligand complex is assumed to be the average of the ligand 
fields of homogenous complexes of the constituent ligands. The reality 
is, biological metal complexes are hardly ever homogenous and hence 
this device has to be used to make coordination predictions in 
structural elucidation studies. 
In solution, water molecules normally occupy the axial positions of 
copper complexes. The coordination of other ligands at these sites has 
an additional influence on the energy of the d-d electronic transitions. 
The presence of the fifth atom in the coordination sphere of the metal 
ion results in what is called the penta-ammine effect. A bathochromic 
shift is brought about by two axially coordinated sites. The presence of 
these groups in the coordination sphere results in the partial loss of 
the degeneracy of the orbital and the overall crystal field splitting 
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4.1.6 Spectral Jata Analysis. 
The Beer-Lambert law19 states that the absorbance (A) of light by a 
sample is directly proportional to the pathlength and the 
concentration of the absorbing species represented as: 
A = £cl ----2 !:: Abs coefficient 
This is a straightforward relationship if the sample contains only one 
absorbing species. In the case of complexometric titration solutions, 
there may be many absorbing species in the solution and so the A of a 
sample of the reaction mixture will be dependent on the 
concentrations of all the component species and their characteristic 
absorption cOefficients Equation 2 will then become: 
A = 1 (£lCl + £2C2 + £3C3 + ... £nCn) ----3 
= 12:£ici 
At different pH values the concentrations of different species will vary 
and so will A. This can be represented as: 
AHI = 1 (£lCIHI -+ £2C2Hl+ £3C3HJ+ ... £nCnHl) ---- 4 
= !Z£iCiHI 
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where AHI is the total measured A at the first pH value and the £lCIHl is 
the A of species i at the first value of pH. The same applies to the 
subsequent values of pH up to the xth (equation 7), for all the species 
up to the nth species. If the concentration of the absorbing species at 
each pH value is known (CiHx) then the set of simultaneous equations 
can be solved for £ of each species. Further, if at each value of pH, the 
A is measured over a range of wavelengths the total A of the sample at 
each wavelength will be: 
A,\l = I (£H,lCl + ':2MC2 + £3,\lC3 + ... £nMCn) ----6 
= 12:£i,\lCi 
A,\x 1 (£\,\xCl + (.2,\xC2 + £3,\xC3 ... (.n,\xCn) ----7 
12:£iA.xci 
where AM in equation 6 is the total A at a specific wavelength and (.i,\lCi 
is the A of species i at this wavelength. The range of equations for total 
A can be solved iteratively for the value of (. for each of the component 
species of the chemical system. The calculations of the solutions for (. 
can be done using a specially designed computer programme that 
requires an input file with all the information relevant to the chemical 
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The information includes amongst other parameters the concentration 
values for eae h of the chemical species present in the reaction 
solution. These concentration values are calculated on the basis of the 
stability constants found by glass electrode potentiometry.19 The 
values of £. are then plotted against wavelength to give a deconvoluted 
spectrum shoV\ing the absorption band of each chemical species. 
If the stability constants and hence the concentrations are not correct, 
the deconvoluted spectrum will be disjointed and this is indicative of a 
wrong chemical model. Having electronic absorption spectral 
information fo::- each of the complex species thus affords a way of 
inferring the nature of the ligand field environment of the central 
metal ion. 
The spectrophotometric method assists in the confirmation of a 
chemical model proposed by some other means such as 
potentiometry, and simultaneously in finding the coordination 
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4.2 Experimental Spectroscopy 
4.2.1 Instrumentation and Chemicals 
HP 84S2A Diode-Array Spectrophotometer 
lSmm Cell/Cuvette 
pH meter 
Combined glass electrode 
Acid O.lM HCl ampoule 
Base O.1.M NaOH ampoule 
Background Electrolyte O.ISM NaCl 
4.2.2 Preparati·:m of Solutions 
The solutions for the UV /Visible spectroscopy were prepared as in 
potentiometry. The solutions for the nuclear magnetic resonance 
(NMR) studies were prepared in D20 instead of distilled water. 
Solutions prepared were acid, base, metal ion both 0-CD and 
SO%MeOH/H20 were used in the solutions of the ligand. The chemical 
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4.3 Experiments 
4.3.1 UV /Visible Spectrophotometry 
4.::: .. 1.1 CuGlv conditions 
In order to demonstrate that the experimental and data analysis 
procedures work the well-known Cu \ Glycine system was studied. The 
concentration of the ligand was maintained at O.OlM at 1:2 fixed 
metal to ligand (M:L) ratio. The experiments were carried out in base 
increments and a distinctive colour change was noted as the 
experiments progressed. This was because the speciation of the 
glycine solution changes with pH and the different complex speCIes 
have different absorption spectra. Water was used as a reference. 
4.3.1.2 DCL conditions. 
The concentration of the ligand was maintained at 8 x10-4M as in 
potentiometric titration where the working pH range was obtained. 
The experimer.ts were carried out in 50% MeOHjH20 from high to low 
pH values, as the ligand forces the use of acid instead of base. 
Methanol was used as reference in these titrations. 
4.3.1.3 CuDCL conditions. 
The concentr3.tion of the ligand in these experiments was also 
maintained at 8 xlO-4M as in potentiometric titration where the 
working pH range was obtained. A 1:2 mole ratio of the M:L was 
maintained. Methanol was used as reference for these titrations with 
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4.3.2 Data Analysis for CuGly data. 
Only the CuGly data could be analysed because of its chemical shifts. 
These data were analysed by the UV -spectra programme for the 
analysis of the molar absorptivity (8), being the characteristic of the 
molecular electronic spectra. The input file to this programme 
specified include: 
• The number of pH points investigated. 
• The number of chemical species proposed 
including the metal ion. 
• The number of wavelengths at which absorbance 
readings were taken at each pH. 
These were then followed by: 
Lastly as input were: 
The concentrations of the individual chemical 
species at each pH. Calculations of these 
concentrations were performed by the use of 
the programme SPEC (being a task to 
calculate the speciation of the species as a 
function of pH) found in ESTA. 
The recorded absorbance values of the titration solution at each pH 
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4.3.3 Other Studies. 
Because of the failure of UV jVisible spectroscopy to give meaningful 
results on copper complexation of DCL, NMR and blood plasma 
modelling werE done. 
4.3.3.1 NMR Spectroscopy 
NMR spectrosc opy has been investigated for this particular ligand 
diclofenac. ThE' purpose of the study was to see where exactly the 
metal ion Cu(IJ) would complex or bind to the ligand, be it to the 
amine group (in-between the phenyl groups) or the carboxylic group. 
Because of the low solubility of DCL the aim of this additional study 
was not fulfilled either as the technique requires high concentrations. 
4.3.3.2 Blood Plasma Modelling 
Metal ions p12,y an important role in biological systems. Metals like 
Ca2+, Mg2+, Mn2+, Fe2+, C02+, Cu2+ and Zn2+ are considered to be 
essential for health in humans.24 There are also those metals that are 
considered to be toxic to the human system. These are Pb2+, Hg2+ and 
Cd2 +, which tend to compete with the essential metal ions for binding 
sites on the ligands of blood plasma. Therefore, it is not presently 
possible to set up a single simulation of blood plasma because of large 
number of compositions found in the plasma,25 as the model contains 
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So the concept of plasma mobilising index (p.m.i) is used to study the 
selectivity of the ligand towards Cu(Il), the p.m.i being defined as the 
ratio of the total concentration of low molecular weight (1.m.w) metal 
complex species in the presence of the drug to that of the normal 
plasma. 26 In addition, this p.m.i is a measure of the ability of the 
administered ligand to move metal ion to the l.m.w fraction. 
The model als) functions by assessing a particular system under in 
vitro conditions at manageable concentrations. The effects are then 
diluted to in vivo conditions by using appropriate mass balance 
equations. 26 So to understand the effect of the ligand on the equilibria, 
formation constants for the ligand together with the species 
determined ir. vitro are entered in the ECCLES (Evaluation of 
Constituent Concentration in Large Equilibrium Systems)27 computer 
program 
4.4 Results. 
Table 6 below shows the results of CuGly in UV jVisible. 
Table 6: ),max (nm) corresponding to E (moPdm3cm-1) for various Cu(IIJ 
species formed in solution with Glycine with data of stability constants 
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4.5 Discussion 
4.5.1 CuGly system 
Because copper forms coloured complexes with glycine the solution 
structure of the complexes could be studied by UV jVisible 
spectrophotometry. Figure 12 below shows the UV jVis. spectra of 
CuGly system as a function of pH. 
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As can be seen, at each pH, a single peak is observed. As the pH is 
increased there is a bathochromic shift in Amax and the intensity of the 
peak increases. This shift indicates increased ligand field splitting of 
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In order to determine the structures of the individual species we need 
their spectra. Using deconvolution techniques as explained in section 
4.3.2, the spectra in Figure 13 are obtained. The spectrum of the 
hexaaqua copper complex is as expected. 
Cu(II) exists as the 1 1 0 species between pH 3-8 with a Amax of 690nm. 
f: of this species is 32 mol-1dm3cm- 1 which is typical of Cu(II) in an 
octahedral environment. The ligand at Amax of 650nm is doubly 
coordinated to the metal ion and f: in this complex is 42 mol-1dm3cm- 1. 
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4.5.2 DCL system 
The problem of precipitation below pH 5 when ~CD medium was 
used forces the use of 50% MeOHjH20 medium. Firstly, before acid 
increments were added to the solution, the ligand was scanned for 
absorbance in the wavelength range selected (see Figure 14 below). 








- pH 3.22 
- pH 2.89 
oe=====~~~~~ 
400 450 soo 550 600 
Wavelength 
650 700 750 
Figure 14 above is the spectrum of the ligand DCL in 50%MeO H j H20. 
At this concentration there was no visible absorption. 
4.5.3 CuDCL system 
For UV jVisible spectrophotometry, it was impossible to get any 
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The spectrum of a ligand together with a metal ion is shown in 
Figure 15 below. The purpose of this study was to check the structure 
of the complex formed when a copper metal ion was added to the 
ligand. 
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4.5.4 NMR spectroscopy 
4.5.4.1 NMR study in SO%MeOH/H20 
The spectrum of a 6 xl0-2M solution of DCL in D20 at pH B.3 is 
shown in Figure 16 below. However, once again as the pH was lowered 
the ligand precipitated. Also after addition of the metal ion a white 
precipitate (Cu(OH)2) was formed. For this reason it was not possible 
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Figure 16. NMR Spectra [or DeL in 50%MeOHIH20 at conc. 0[6 xl (}2M. 
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4.5.4.2 The NMR study in B-CD. 
Solubility of DCL in 50% MeOH/D20 was insufficient to obtain 
reasonable NMR spectra. For this reason I3-CD was used in an 
attempt to increase the solubility. Figure 17 below, shows the proton 
chemical shifts of DeL as a function of I3-CD concentration. 
Figure 17. NMR data analysis of DCL protons in B-CD . 
7 
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The results obtained when I3-CD was used were then compared with 
previously published results. J.A. Arancibia23, managed to observe a 
downfield shift of approximately 0.05ppm in the resonances for 
protons in the phenyl ring holding an acetate group, in his studies 
performed in DMSO. This then provides him with evidence that this 
phenyl ring is the only molecular moiety involved in the complex 
formation between DCL and I3-CD.23 But in our experimental analysis 
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4.5.5 Computer Speciation Modelling 
4.5.5.1 Intestinal Absorption 
Page 83 
Dic10fenac is administered orally in a tablet form with a dosage of 
50mg or 75mg. The volume of a human stomach as outlined by G. B. 
Johnson31 ranges from 4 L - 4000ml (full stomach) to 0.08 L - 80ml 
(empty stomach). Then if one assumes an average stomach volume is 
150ml then it corresponds to a concentration range of 1.05 x10-3M to 
1.57xlO-3M. lL the alimentary canal the DCL encounters a variety of 
pH conditions where in the stomach it is subjected to a pH of 2 while 
in the intestines the pH is -7.8. 
At a total DCL concentration of 8 X10-4M in 50% MeOHjH20 medium, 
the titration data showed that protonated DCL precipitates below pH 
3.1. Using a protonation constant of 4.82 for DCL a solubility product 
of 5.5 x10-8M·! for the protonated DCL can be calculated. Figure 18 
shows the speciation of DCL as a function of pH at a total 
concentration of 1.57 xlO-3M. On the same axes the total dissolved 
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Figure 18: Ligand speciation of1.S7 x10"3M DeL as a function of pH 
1.80E-03 
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At pH 2, DCL is in the protonated fonn and only 9% of the ligand is 
dissolved. Above this pH there is a rapid increase in the amount of 
dissolved DCL. At the same time the DCL is deprotonated such that at 
pH 4.8 it exists as a 50:50 mixture of HDCL and DCL-. At pH values of 
6 to 8, typical of the intestines, DCL is exclusively in the deprotonated 
fonn and is fully soluble. 
Phannaceu tical modification of drug molecules by inclusion in host 
compounds has been extensively developed to improve their solubility, 
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A typical case is the microencapsulation of drug molecules in 
cyclodextrins (CD's) which has been observed to produce more stable 
drug preparations with improved bioavailability.19 Our experimental 
data on DCL/~-CD system showed that at a DCL concentration of 8 
xlO-4M precipitation occurred at pH 4.5. Using this pH and using a 
protonation constant of 4 .29 for encapsulated DCL, a solubility 
product of 6.9 x 10-8 M2 is calculated. Interestingly, there is very little 
difference between the solubility products of DCL in the two media. 
However there is a significant difference in the solubility. Figure 19 
shows the speciation of DCL in ~-CD medium as a function of pH. 
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The speciation plot confirms that the solubility of DCL has been 
improved to 1.35 xlO-3M at pH 2 compared to 1 xlO-4M around the 
same pH when methanol medium was employed. This is because of 
the difference in protonation constants. 
The main aim of this study was to investigate the complexation of 
Cu(II) by DCL. Then, 50% MeOH/H20 medium was used because of 
its better working pH range when compared to f3 -CD medium. Figure 
20 shows a species distribution graph of CuDCL as a function of pH in 























































Between pH 0 and 2, the free Cu 2+ and the protonated DCL exist. The 
1 1 0 species reaches a concentration of 4 xlO-4M at pH 5.5. Above pH 
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These results show that even though Cu(II) is weakly coordinated to 
DCL, in the absence of competing ligands the complex would exist in 
the intestines. This may well affect the bioavailability of the DCL and 
the Cu(Il). 
4.5.5.2 The copper p.m.i 
In the blood plasma there are other competing ligands found so the 
CuDCL complex was exposed to such kind of environment. In the 
calculation of the p.m.i of Cu2+, the ligand concentration was varied 
over the range of 10-9 to 10-4 mol dm-3 • The stability constants were 
also entered mto ECCLES program, the blood plasma model, to 
evaluate the bioavailability of the copper ions from complexes 
determined. The iterations were done at pH 7.4 and the log p.m.i for 
Cu2+ is consta:1.t at 0.00 throughout the concentration range. The log 
p.m.i is normally plotted against the log of the concentration of the 
ligand. A high p.m.i of any ligand indicates strong metal ion chelation 
at very low ligand concentrations. But it was impossible to plot the 
graph under these conditions. 
The results st.ows that the ligand is devoid of any Cu(II) mobilising 
ability. The fact that the metal p.m.i is 0.00, this can be due to the 
weak complexes formed by Cu(II) with DCL. In conclusion, the DCL is 
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5. Conclusion 
The anti-inflarr,matory activity of metal complexes of NSAIDs has been 
known for rr,any years. Previous studies have shown copper 
compounds to have anti-inflammatory activity. 1 The objectives in 
designing copper-based anti-inflammatory drugs has been to increase 
the concentration of the low molecular weight copper in plasma. l 
Although the mechanism of action by which copper exhibits anti-
inflammatory activity is not yet understood, several possibilities exist. 
Whatever its mode of action, the importance of copper at the site of 
inflammation has been sufficiently established and hence its 
manipulation by pharmaceuticals IS essential. This therefore 
represents the justification for studying Cu(II) complexes, particularly 
with respect to their copper mobilising ability.2 
Furthermore much pharmacological evidence suggests the use of 
copper complex:es to be beneficial in the alleviation and treatment of 
RA. Thus Sorenson1 demonstrated that the anti-inflammatory activity 
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Diclofenac, th~ ligand of interest is used to treat inflammation 
associated with RA. It has been postulated that the activity of this 
drug would be increased by complexation with copper. The objective of 
this study was to investigate this claim and to elaborate any 
underlying chemical basis for it. 
For the ligand to meet the requirements of copper in vivo mobilisation, 
it must possess several thermodynamically desirable characteristics. 
These vary according to the particular metal ion being considered. 
Unfortunately, enhanced stability is not the only criterion for 
successful mobilisation, but selectivity as well as other physical 
attributes of the complex plays an important role. 
There are several different ways of achieving selective thermodynamic 
binding. Of these the most important for controlling the selection of 
copper are the types of ligan ding donor atoms, the preferential co-
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Because of solubility limitations the system was studied in 50% 
MeOH/H20 an:} !)-cyclodextrin (!)-CD) as a carrier molecule and then 
protonation constants of 4.82 and 4.29 were obtained for the two 
media respectvely. It was not possible to investigate the copper 
complex of the ligand using the !)-CD environment. 
The only log stability constants obtained were 3.48 and -3.02 for the 1 
1 0 and 1 1 -1 species respectively in 50% MeOH/H20. Cu(II) shows a 
remarkable ability to form bonds at pH -7 to peptide and amide 
nitrogens in their ionised state.3 However in this study, as the amine 
nitrogen has a very low basicity and so, at pH > 4.8, the copper 
precipitates out of solution. 
Based on pKa values the solubility products of 5.5 xIO-8M2 and 6.9 
xIO-8M2 were calculated for the protonated DCL. The improvement in 
solubility products is due to the difference in protonation constants 
for the two media used. Computer simulation of intestinal absorption 
indicates that the CuDCL complex would exist at pH > 5. In this way 
the bioavailablity of both copper and DCL is improved. However 
blood plasma simulation studies indicated that the ligand is devoid of 
any Cu(II) mobilising ability. This can be due to the weak complexes 













~C~h=a=p~t=er~F~iv~e~ _____ C~onclu~s=i~o~n~ ___________ ~P~a~g~e~9~1 
Also, the study enriches the knowledge of dic10fenac with some 
aspects of its complexing ability and although the reaction medium is 
very different from the biological environment. However the obtained 
results enable to suppose that the administration of this drug for long 
time could decrease the bioavailability of some important metal ions. 
In fact diclofenac reacts vvith divalent metal ions forming 1:2 (metal to 
ligand ratio) very slightly water-soluble complexes. Therefore, DCL is 
unable to increase the l.m.w Cu(II) fraction. 
Improvements in the stability of the ligand may be the increase in its 
number of electron donor atoms or a slight change in the whole ligand 
has to be done. Also if the number of chelate rings on the ligand can 
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